BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld Science 2025 review
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 22, 2025
Home » Topics » Briefs » Regulatory actions

Regulatory actions
Regulatory actions RSS Feed RSS

Regulatory actions for Aug. 20, 2025

Aug. 20, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Aldeyra, Altimmune, Antengene, Astrazeneca, Biontech, Iovance, Pfizer, PTC, Regenxbio, Sanofi.
Read More

Regulatory actions for August 19, 2025

Aug. 19, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Onward Medical, Masimo, Zai Lab.
Read More

Regulatory actions for Aug. 19, 2025

Aug. 19, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: BMS, Merck, Newamsterdam, Novo Nordisk, Soligenix, Springworks, Stealth, Systimmune, Tonix, Valneva.
Read More

Regulatory actions for August 19, 2025

Aug. 19, 2025
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biodlink, Neurizon.
Read More

Regulatory actions for August 18, 2025

Aug. 18, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Catheter Precision, Cynosure Lutronic, Neuroone Medical.
Read More

Regulatory actions for Aug. 18, 2025

Aug. 18, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Invyvid, Neurizon, Omeros, Precigen.
Read More

Regulatory actions for August 15, 2025

Aug. 15, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Mainz Biomed.
Read More

Regulatory actions for Aug. 15, 2025

Aug. 15, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Beam, Everest, Halda, Sanofi, Shilpa.
Read More

Regulatory actions for August 14, 2025

Aug. 14, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Deepsight, Sonic Incytes.
Read More

Regulatory actions for Aug. 14, 2025

Aug. 14, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Biodlink, Creative Medical, Insmed, Kexing, Ocugen, Savara.
Read More
Previous 1 2 … 15 16 17 18 19 20 21 22 23 … 323 324 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Rubber duck dressed up as a doctor

    In 2025, science’s biggest story was political

    BioWorld
    In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
  • Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis

    BioWorld Science
    Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing